WallStSmart
AMLX

Amylyx Pharmaceuticals Inc

NASDAQ: AMLX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$14.73
-3.09% today

Updated 2026-05-08

Market cap
$1.69B
P/E ratio
P/S ratio
0.66x
EPS (TTM)
$-1.48
Dividend yield
52W range
$4 – $19
Volume
1.1M

Amylyx Pharmaceuticals Inc (AMLX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+4.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+11.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-2.0%
Last 4 reports
Positive reaction rate
25%
1 of 4 quarters
Largest single-day move
+7.6%
2026-04-01
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-01$-0.37-7.3%$13.90$14.95+7.6%
2026-03-03$-0.30+11.8%$15.30$15.05-1.6%
2025-11-06$-0.37+14.0%$13.24$12.31-7.0%
2025-08-07$-0.46-2.2%$8.19$7.64-6.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.34$-0.37-7.3%
2025-12-31$-0.34$-0.30+11.8%
2025-09-30$-0.43$-0.37+14.0%
2025-06-30$-0.45$-0.46-2.2%
2025-03-31$-0.50$-0.42+16.0%
2024-12-31$-0.56$-0.55+1.8%$-665000.00-100.6%
2024-09-30$-0.56$-1.07-91.1%$416000.00-99.6%
2024-06-30$-0.82$-0.62+24.4%$-1.02M
2024-03-31$-0.01$-0.12-1100.0%$88.64M
2023-12-31$0.23$0.07-69.6%$108.45M
2023-09-30$0.44$0.30-31.8%$102.69M

Frequently asked questions

Has Amylyx Pharmaceuticals Inc beaten earnings estimates?
Amylyx Pharmaceuticals Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +4.0% over the last 4 quarters.
How does AMLX stock react to earnings?
AMLX stock has moved an average of -2.0% in the trading day following earnings over its last 4 reports, with positive reactions in 25% of those quarters.